Dimopoulou I, Ilias I, Mastorakos G, Mantzos E, Roussos C, Koutras D A
Department of Pulmonary and Critical Care Medicine, Evangelismos General Hospital, Athens, Greece.
Metabolism. 2001 Dec;50(12):1397-401. doi: 10.1053/meta.2001.28157.
To investigate thyroid function in chronic obstructive pulmonary disease (COPD), 46 consecutive patients (35 men) with stable, mild-to-severe disease, having a mean (SD) age of 67 +/- 7 years were studied. All subjects underwent pulmonary function tests (PFTs), arterial blood gas determination, and measurement of serum total thyroxine (TT4), total triiodothyronine (TT3), resin T3 uptake (RT3U), reverse triiodothyronine (rT3), and thyroid-stimulating hormone (TSH) levels. The free thyroxine and free triiodothyronine indexes (FT4I = RT3U/30TT4 and FT3I = RT3U/30TT3, respectively) along with the TT3/TT4 ratio were calculated; the latter was used as a marker of peripheral conversion of thyroxine into triiodothyronine. Interleukin (IL)-6 was also measured to evaluate its potential associations with thyroidal hormone levels. On the basis of forced expiratory volume in 1 second (FEV1), patients were divided in 2 groups: group 1, (FEV1 > or = 50% of predicted, n = 26), with mild-to-moderate COPD and group 2 (FEV1 < 50% of predicted, n = 20) having severe disease. All subjects had normal serum thyroid hormone levels; for the entire COPD population, mean values were 7.80 +/- 1.60 microg/dL for TT4, 1.12 +/- 0.20 ng/mL for TT3, 29.0 +/- 1.88 for RT3U, 7.54 +/- 1.34 for FT4I, 1.07 +/- 0.16 for FT3I, 18.71 +/- 5.89 ng/dL for rT3, and 1.15 +/- 0.6 microU/mL for TSH. Mean TT3/TT4 ratio was 0.14 +/- 0.03. In group 1, TT3, TT4, and TT3/TT4 ratio did not correlate with age, FEV1, PaO2, or inhaled corticosteroids. Similarly, in group 2, TT3 and TT4 were unrelated to the above-mentioned variables; however, there was a strong positive correlation between TT3/TT4 ratio and PaO2 (r =.61, P =.004). IL-6 was within normal limits in all subjects, and it did not correlate with any thyroid hormone either in group 1 or in group 2. It is concluded that in stable COPD, severity of disease through hypoxemia is important in determining the peripheral metabolism of thyroid hormones. Whether this constitutes an adaptation is not known.
为研究慢性阻塞性肺疾病(COPD)患者的甲状腺功能,我们对46例连续入选的病情稳定、轻至重度的患者(35例男性)进行了研究,他们的平均(标准差)年龄为67±7岁。所有受试者均接受了肺功能测试(PFTs)、动脉血气测定以及血清总甲状腺素(TT4)、总三碘甲状腺原氨酸(TT3)、树脂T3摄取率(RT3U)、反三碘甲状腺原氨酸(rT3)和促甲状腺激素(TSH)水平的测定。计算了游离甲状腺素和游离三碘甲状腺原氨酸指数(FT4I = RT3U/30TT4和FT3I = RT3U/30TT3)以及TT3/TT4比值;后者用作甲状腺素外周转化为三碘甲状腺原氨酸的标志物。还测定了白细胞介素(IL)-6以评估其与甲状腺激素水平的潜在关联。根据第1秒用力呼气量(FEV1),患者被分为两组:第1组(FEV1≥预计值的50%,n = 26),为轻至中度COPD;第2组(FEV1<预计值的50%,n = 20),为重度疾病。所有受试者的血清甲状腺激素水平均正常;对于整个COPD人群,TT4的平均值为7.80±1.60μg/dL,TT3为1.12±0.20ng/mL,RT3U为29.0±1.88,FT4I为7.54±1.34,FT3I为1.07±0.16,rT3为18.71±5.89ng/dL,TSH为1.15±0.6μU/mL。平均TT3/TT4比值为0.14±0.03。在第1组中,TT3、TT4和TT3/TT4比值与年龄、FEV1、PaO2或吸入性糖皮质激素均无相关性。同样,在第2组中,TT3和TT4与上述变量无关;然而,TT3/TT4比值与PaO2之间存在强正相关(r = 0.61,P = 0.004)。所有受试者的IL-6均在正常范围内,且在第1组或第2组中,它与任何甲状腺激素均无相关性。结论是,在稳定期COPD中,通过低氧血症反映的疾病严重程度在决定甲状腺激素的外周代谢方面具有重要意义。这是否构成一种适应性变化尚不清楚。